Last reviewed · How we verify

Solution For Thoracic epidural block

Wake Forest University Health Sciences · FDA-approved active Small molecule

A local anesthetic solution administered via thoracic epidural injection that blocks nerve conduction in the thoracic spinal region to provide anesthesia and analgesia.

A local anesthetic solution administered via thoracic epidural injection that blocks nerve conduction in the thoracic spinal region to provide anesthesia and analgesia. Used for Thoracic epidural anesthesia for surgical procedures, Thoracic epidural analgesia for postoperative pain management.

At a glance

Generic nameSolution For Thoracic epidural block
Also known asLidocaine, Epinephrine
SponsorWake Forest University Health Sciences
Drug classLocal anesthetic
ModalitySmall molecule
Therapeutic areaAnesthesia
PhaseFDA-approved

Mechanism of action

Thoracic epidural block solutions typically contain local anesthetics (such as bupivacaine or ropivacaine) that are injected into the epidural space surrounding the spinal cord in the thoracic region. These agents reversibly block sodium channels in nerve fibers, preventing action potential propagation and resulting in loss of sensation and motor function in the distribution of blocked nerves. This technique is used for perioperative anesthesia and postoperative pain management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: